1. Gohda E, Yamasaki T, Tsubouchi H, Kurobe M, Sakiyama O, Aoki H, Niidani N, Shin S, Hayashi K, Hashimoto S, Daikuhara Y, Yamamoto I. Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure.Biochim Biophys Acta 1990; 21: 1053.
2. Karvountzis GG, Redeker AG, Peters RL. Long term follow-up studies of patients surviving viral hepatitis.Gastroenterology 1974; 67: 870.
3. Bernuau J. Fulminant and subfulminant hepatitis: liver regeneration and prognosis. In: Bernuau D, Feldmann G.Liver regeneration. Paris: John Libbey Eurotext; 1992: 147–157.
4. Terpstra OT, Schalm SW, Weimar W, Willemse PJA, Baumgartner D, Groenland THN, Ten Kate FWJ, Porte RJ, De Rave S, Reuvers CB. Auxiliary partial liver transplantation for endstage chronic liver disease.N Engl J Med 1988; 319: 1507–1511.
5. Metselaar HJ, Hesselink EJ, De Rave S, ten Kate FS, Lameris JS, Groenland TH, Reuvers CB, Weimar W, Terpstra OT, Schalm SW. Recovery of failing liver after auxiliary heterotopic transplantation.Lancet 1990; 335: 1156–1157.